Tamsi, Aurea D.

HRN: 24-78-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2024
CEFTRIAXONE 1G (VIAL)
04/02/2024
04/08/2024
IV
1gram
Q12hrs
CAP-LR; Fracture Losed Right Pelvis; Abdominal Mass Probably Benign; DM Type 2 Uncontrolled
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: